LOBEFARO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 153
EU - Europa 69
AS - Asia 25
OC - Oceania 3
AF - Africa 2
Totale 252
Nazione #
US - Stati Uniti d'America 147
IT - Italia 44
GB - Regno Unito 8
CA - Canada 6
IQ - Iraq 6
JP - Giappone 6
FR - Francia 4
IE - Irlanda 4
AU - Australia 3
IR - Iran 3
SG - Singapore 3
CN - Cina 2
ES - Italia 2
ID - Indonesia 2
MA - Marocco 2
NL - Olanda 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
DE - Germania 1
IN - India 1
PH - Filippine 1
SE - Svezia 1
TR - Turchia 1
Totale 252
Città #
Ashburn 13
Fairfield 11
Santa Cruz 11
Lubbock 10
Buffalo 8
Wilmington 7
Erbil 6
Milan 6
Rho 6
Seattle 6
Cambridge 5
Woodbridge 5
Ann Arbor 4
Boardman 4
Dublin 4
Houston 4
Southend 4
Stanford 4
Hay Point 3
Atlanta 2
Avezzano 2
Bibiana 2
Dallas 2
Fleming Island 2
Kenitra 2
Kumamoto 2
Marble Falls 2
Monza 2
Ottawa 2
Padova 2
Pontefract 2
Salerno 2
Tokyo 2
Winnipeg 2
Ankara 1
Beijing 1
Bellevue 1
Bengaluru 1
Cedar Knolls 1
Chandler 1
Chicago 1
Columbus 1
Denver 1
East Lansing 1
El Ejido 1
Ferrara di Monte Baldo 1
Hillsboro 1
Iowa City 1
Kofu 1
Kyoto 1
Las Vegas 1
Montgomery 1
Montreal 1
Munich 1
Murcia 1
Naples 1
Nashville 1
Omaha 1
Pisa 1
Reston 1
Santa Clara 1
Shanghai 1
Stockholm 1
Toronto 1
Totale 181
Nome #
The landscape of actionable gene fusions in colorectal cancer, file dfa8b9a0-7c6f-748b-e053-3a05fe0a3a96 83
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State, file f2efcc28-8b3f-4a3d-87b5-27f673e8f84a 61
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma : Myth or Reality?, file dfa8b9a3-bf5f-748b-e053-3a05fe0a3a96 57
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications, file 9925aec8-6b35-42ec-ba83-700fe8d975a5 30
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab, file dfa8b9a9-b059-748b-e053-3a05fe0a3a96 12
PillarX: A Microfluidic Device to Profile Circulating Tumor Cell Clusters Based on Geometry, Deformability, and Epithelial State, file 26b45c5a-e743-4972-834a-2f5ec55ccb56 3
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology, file dfa8b9a9-871b-748b-e053-3a05fe0a3a96 3
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer, file dfa8b9a9-d4d9-748b-e053-3a05fe0a3a96 3
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer, file dfa8b9a0-7c6b-748b-e053-3a05fe0a3a96 2
Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers, file dfa8b9a9-cd81-748b-e053-3a05fe0a3a96 2
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program, file dfa8b9a9-dff5-748b-e053-3a05fe0a3a96 2
“Systemic strategy at the patient’s service”: A congress report on supportive care in oncology, file dfa8b99a-5b9d-748b-e053-3a05fe0a3a96 1
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin, file e44ab2a8-aad2-4311-bde7-0a6ad4f36ffa 1
Totale 260
Categoria #
all - tutte 482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181 0000 00 00 0001
2019/202014 0000 00 00 7412
2020/202153 1345 27 72 41143
2021/202252 1331 23 29 31159
2022/2023140 22128 410 1329 2619150
Totale 260